Logo

Indications - This is indicated for-  The maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).  The maintenance treatment of asthma in patients aged 18 years and older. Limitation of use: Not indicated for relief of acute bronchospasm.

Dosage & Administration - This inhalation capsule must not be swallowed. Only to be used with the device. Remove the capsule from the blister pack only immediately before using it in the inhalation device. After inhalation, rinse your mouth with water without swallowing to reduce the risk of oropharyngeal candidiasis. Adults (18 years or older): Should be used at the same time every day, not more than once every 24 hours. If shortness of breath or other asthma symptoms arise in the period between doses, an inhaled SABA (Short Acting β-Agonist) should be taken for immediate relief. Maintenance treatment of COPD: 1 inhalation capsule once daily. Maintenance treatment of Asthma: 1 inhalation capsule once daily.

Side Effects - COPD: Most common adverse reactions (incidence ≥1%) are upper respiratory tract infection, pneumonia, bronchitis, oral candidiasis, headache, back pain, arthralgia, infuenza, sinusitis, pharyngitis, rhinitis, dysgeusia, constipation, urinary tract infection, diarrhea, gastroenteritis, oropharyngeal pain, cough, and dysphonia. Asthma: Most common adverse reactions (incidence ≥2%) are pharyngitis/nasopharyngitis, upper respiratory tract infection/viral upper respiratory tract infection, bronchitis, respiratory tract infection/viral respiratory tract infection, sinusitis/acute sinusitis, urinary tract infection, rhinitis, infuenza, headache, and back pain

Contraindications -  Primary treatment of status asthmaticus or acute episodes of COPD or asthma requiring intensive measures  Severe hypersensitivity to milk proteins or any ingredients.

Others - Pregnancy & Lactation Insufficient data on the use of this preparation in pregnant women and lactating mothers.